Biogen Drug Sends Tau Into Reverse: An Alzheimer’s Breakthrough In The Making?

60% Reduction In Tau Exceeds Expectations

Biogen
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D